{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP05062",
    "Peptide Name": "Haloganan (Hgn, HG1 L3Q,A19K, Synthetic AMPs, homodimer, Halocidin analog, UCSS2a, XXA)",
    "Source": "amino acid SUBSTITUTION, animal-derived, natural derivatives",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "KWQNALLHHGLNCAKGVLK",
    "Sequence Length": 19,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 6,
    "Boman Index": 0.62,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "47%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is 89.47% similar toHG1L: 21%, K: 16%, A=G=N=H: 11%. Warning: chain B sequence is the same as chain A.Chemical modification: there is an intermolecular S-S bond between the two chains.Activity: active against S. aureus MRSA (MIC 4 ug/ml),  B. subtilis KCTC 2213 (MIC 1 ug/ml), M. luteus KCTC 9341 (MIC 2 ug/ml), vancomycin-resistant E. faecium strain CCARM 5028 anti-VRE (MIC 4 ug/ml), multidrug-resistant L. monocytogenes CCARM 2161 (MIC 4 ug/ml), P. aeruginosa CCARM 2161 MDRPA (MIC 4 ug/ml), E. coli KCTC 1039 (MIC 4 ug/ml), K. oxytoca KCTC 1686 (MIC 4 ug/ml), C. freundii KCTC 2359 (MIC 4 ug/ml), S. enterica KCTC 2930 (MIC 4 ug/ml), 5 strains C. albicans (MIC 8-16 ug/ml). More to be added.",
    "Author": "Shin SH, Kim B, Park S, Jo S, Lee IH. 2014",
    "Reference": "Peptides. 2014 Dec;62:137-43. doi: 10.1016/j.peptides.2014.09.025.PubMed",
    "Title": "Haloganan: a novel antimicrobial peptide for treatmentof wound infections."
  },
  "3D Structure": []
}